MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Let’s Talk Medtech

How Guardant Is Redefining Cancer Detection

IMG_2022-9-9-035029.png
Guardant Health’s co-founder and CEO, Helmy Eltoukhy reveals how the company has been making huge waves in the field of liquid biopsy.

For the past 10 years, Guardant Health has been defining the liquid biopsy space and has been a pioneer of sorts in the cancer detection market. The private company was one of the first in the space to go public and has secured a few FDA approvals to boot.

Guardant’s CEO and Co-founder Helmy Eltoukhy joins us for this episode of Let’s Talk Medtech to discuss the company’s past, present, and future. We also discuss the evolution of liquid biopsy and why the method holds so much promise for cancer detection.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Find IVD Suppliers

Find suppliers of biochemicals, reagents, filters, membranes, assay system components, and contract manufacturing to the IVD sector on Qmed, the world's only director of pre-qualified suppliers to the medical device and diagnostics industry.